Home › Lupus › District of Columbia
Lupus clinical trials in District of Columbia
5 studies for Lupus are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT03816345An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Washington D.C.
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 30, 2026 · NCT05835310Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Children's National Health System, Washington D.C.
RecruitingObservational study
Ages 5 to 21 · All sexes · Updated Jul 24, 2026 · NCT04833465Lupus Landmark Study: A Prospective Registry and Biorepository
- Georgetown University, Washington D.C.
RecruitingObservational study
Ages 18 to 110 · All sexes · Updated Apr 15, 2026 · NCT05934149Research Accelerated by You Lupus Registry
- Online Registry - No Physical Site Required, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Jan 23, 2026 · NCT06927219From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.